Status:
NOT_YET_RECRUITING
Comparison of Intralesional Triamcinolone Versus Verapamil for Keloid Treatment
Lead Sponsor:
Nishtar Medical University
Conditions:
Keloid Scars
Eligibility:
All Genders
10-50 years
Phase:
PHASE4
Brief Summary
This study aims to compare the efficacy of intralesional triamcinolone and verapamil in patients presenting with keloid at our local setting. The results will guide us towards better management of kel...
Eligibility Criteria
Inclusion
- size of keloid1-5 cm,
- on any site of the body,
- duration less then five years and
- baseline Vancouver scar score of more the or equal to 5
Exclusion
- Pregnant or lactating women,
- family history of keloids,
- acromegaly, and
- congestive cardiac diseases
Key Trial Info
Start Date :
April 1 2025
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
September 30 2025
Estimated Enrollment :
60 Patients enrolled
Trial Details
Trial ID
NCT06897969
Start Date
April 1 2025
End Date
September 30 2025
Last Update
April 1 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Nishtar Medical University & Hospital
Multan, Punjab Province, Pakistan, 60000